Integrated Filing — IndAS


General information about company

Scrip Code 526247
NSE Symbol PREMEXPLN
MSEI Symbol NOTLISTED
ISIN INE863B01029
Name of company Premier Explosives Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 22-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 14-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment High Energy Materials
Start date and time of board meeting 22-May-2025   12:15:00
End date and time of board meeting 22-May-2025   16:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? No
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-05-22
Indicate Company website link for updated RPT policy of the Company www.pelgel.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 740837000 4174523000
Other income 5093000 21153000
Total income 745930000 4195676000
2 Expenses
(a) Cost of materials consumed 686919000 2682008000
(b) Purchases of stock-in-trade 5756000 16095000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -355750000 -309233000
(d) Employee benefit expense 161221000 619283000
(e) Finance costs 11801000 110955000
(f) Depreciation, depletion and amortisation expense 29307000 114742000
(f) Other Expenses
1 Research and development expenses 925000 4386000
2 Other expenses 146140000 582016000
Total other expenses 147065000 586402000
Total expenses 686319000 3820252000
3 Total profit before exceptional items and tax 59611000 375424000
4 Exceptional items 0 0
5 Total profit before tax 59611000 375424000
6 Tax expense
7 Current tax 36123000 90123000
8 Deferred tax -13500000 -225000
9 Total tax expenses 22623000 89898000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 36988000 285526000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 36988000 285526000
17 Other comprehensive income net of taxes 2120000 -3763000
18 Total Comprehensive Income for the period 39108000 281763000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 107522000 107522000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 2349989000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.69 5.31
Diluted earnings (loss) per share from continuing operations 0.69 5.31
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.69 5.31
Diluted earnings (loss) per share from continuing and discontinued operations 0.69 5.31
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results n



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1905997000
Capital work-in-progress 28473000
Investment property 802000
Goodwill 0
Other intangible assets 70162000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 0
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 52100000
Total non-current financial assets 52100000
Deferred tax assets (net) 0
Other non-current assets 55712000
Total non-current assets 2113246000
2 Current assets
Inventories 1534946000
Current financial asset
Current investments 0
Trade receivables, current 380781000
Cash and cash equivalents 930924000
Bank balance other than cash and cash equivalents 81575000
Loans, current 438000
Other current financial assets 0
Total current financial assets 1393718000
Current tax assets (net) 0
Other current assets 263564000
Total current assets 3192228000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 5305474000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 107522000
Other equity 2349989000
Total equity attributable to owners of parent 2457511000
Non controlling interest
Total equity 2457511000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 75000000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 765000
Total non-current financial liabilities 75765000
Provisions, non-current 106055000
Deferred tax liabilities (net) 134653000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 316473000
Current liabilities
Current financial liabilities
Borrowings, current 371447000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 56605000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1108885000
Total Trade payable 1165490000
Other current financial liabilities 215029000
Total current financial liabilities 1751966000
Other current liabilities 731324000
Provisions, current 17914000
Current tax liabilities (Net) 30286000
Deferred government grants, Current 0
Total current liabilities 2531490000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 2847963000
Total equity and liabilites 5305474000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement on post-employment defined benefit obligation) 2991000 -5309000
Total Amount of items that will not be reclassified to profit and loss 2991000 -5309000
2 Income tax relating to items that will not be reclassified to profit or loss 871000 -1546000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income 2120000 -3763000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 375424000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 110955000
Adjustments for decrease (increase) in inventories -656245000
Adjustments for decrease (increase) in trade receivables, current 483053000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 856641000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 114742000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -15744000
Adjustments for dividend income 0
Adjustments for interest income 13807000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 41532000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 921127000
Net cash flows from (used in) operations 1296551000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 110385000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 1186166000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 44000
Purchase of property, plant and equipment 130595000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 14584000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 7829000
Net cash flows from (used in) investing activities -108138000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -137560000
Repayments of borrowings 72879000
Payments of lease liabilities 0
Dividends paid 26881000
Interest paid 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash -111351000
Net cash flows from (used in) financing activities -348671000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 729357000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 729357000
Cash and cash equivalents cash flow statement at beginning of period 201567000
Cash and cash equivalents cash flow statement at end of period 930924000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Majeti and Co Yes 30-Sep-2026


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 PREMIER EXPLOSIVES LIMIED Dr AMARNATH GUPTA Chairman & Non Executive Director Remuneration 6213000 None 6213000 4130000 3974000
2 PREMIER EXPLOSIVES LIMIED Dr AMARNATH GUPTA Chairman & Non Executive Director Interest paid 88000 None 88000 1838000 0
3 PREMIER EXPLOSIVES LIMIED Dr AMARNATH GUPTA Chairman & Non Executive Director Loan 38189000 None 38189000 38189000 0
4 PREMIER EXPLOSIVES LIMIED Dr AMARNATH GUPTA Chairman & Non Executive Director Dividend paid 6550000 None 6550000 0 0
5 PREMIER EXPLOSIVES LIMIED Dr AMARNATH GUPTA Chairman & Non Executive Director Any other transaction Sitting fee 258000 None 258000 0 0
6 PREMIER EXPLOSIVES LIMIED Dr AMARNATH GUPTA Chairman & Non Executive Director Any other transaction Interest payable refund 1926000 None 1926000 0 0
7 PREMIER EXPLOSIVES LIMIED Dr KAILASH GUPTA Non Executive Director / Relative of Key Management Personnel Any other transaction Sitting fee 168000 None 168000 0 0
8 PREMIER EXPLOSIVES LIMIED Dr KAILASH GUPTA Non Executive Director / Relative of Key Management Personnel Interest paid 265000 None 265000 1844000 0
9 PREMIER EXPLOSIVES LIMIED Dr KAILASH GUPTA Non Executive Director / Relative of Key Management Personnel Any other transaction Repayment of unsecured loans 10034000 None 10034000 10034000 0
10 PREMIER EXPLOSIVES LIMIED Dr KAILASH GUPTA Non Executive Director / Relative of Key Management Personnel Dividend paid 2919000 None 2919000 0 0
11 PREMIER EXPLOSIVES LIMIED Dr KAILASH GUPTA Non Executive Director / Relative of Key Management Personnel Any other transaction Interest payable refund 2109000 None 2109000 0 0
12 PREMIER EXPLOSIVES LIMIED T V CHOWDARY Key Management Remuneration 18931000 None 18931000 4130000 4670000
13 PREMIER EXPLOSIVES LIMIED T V CHOWDARY Key Management Dividend paid 79000 None 79000 0 0
14 PREMIER EXPLOSIVES LIMIED Y DURGA PRASADA RAO Key Management Remuneration 8990000 None 8990000 2065000 2270000
15 PREMIER EXPLOSIVES LIMIED Y DURGA PRASADA RAO Key Management Dividend paid 0 None 0 0 0
16 PREMIER EXPLOSIVES LIMIED PREMIER WIRE PRODUCTS LIMITED Subsidiary Any other transaction Rent paid 119000 None 119000 0 0
17 PREMIER EXPLOSIVES LIMIED PREMIER WIRE PRODUCTS LIMITED Subsidiary Any other transaction Loan taken 37830000 None 0 37830000 37830000
18 PREMIER EXPLOSIVES LIMIED PREMIER WIRE PRODUCTS LIMITED Subsidiary Interest paid 2791000 None 2791000 4514000 2126000
19 PREMIER EXPLOSIVES LIMIED PREMIER WIRE PRODUCTS LIMITED Subsidiary Any other transaction Reimbursement of expenses 91000 None 91000 0 0
20 PREMIER EXPLOSIVES LIMIED PREMIER WIRE PRODUCTS LIMITED Subsidiary Investment 52000000 None 0 52000000 52000000
21 PREMIER EXPLOSIVES LIMIED PREMIER WIRE PRODUCTS LIMITED Subsidiary Any other transaction Interest payable refund 5179000 None 5179000 0 0
22 PREMIER EXPLOSIVES LIMIED ANIL KUMAR MEHTA Independent Director Any other transaction Sitting fee 108000 None 108000 0 0
23 PREMIER EXPLOSIVES LIMIED ANIL KUMAR MEHTA Independent Director Dividend paid 10000 None 10000 0 0
24 PREMIER EXPLOSIVES LIMIED PRABHAKAR RAM TRIPATHI Independent Director Any other transaction Sitting fee 108000 None 108000 0 0
25 PREMIER EXPLOSIVES LIMIED VENKATARAMAN ABBARAJU Independent Director Any other transaction Sitting fee 45000 None 45000 0 0
26 PREMIER EXPLOSIVES LIMIED RAMA RAO KATHIRISETTI Independent Director Any other transaction Sitting fee 108000 None 108000 0 0
27 PREMIER EXPLOSIVES LIMIED LT GEN P R KUMAR Independent Director Any other transaction Sitting fee 218000 None 218000 0 0
28 PREMIER EXPLOSIVES LIMIED LT GEN P R KUMAR Independent Director Dividend paid 0 None 0 0 0
29 PREMIER EXPLOSIVES LIMIED A N GUPTA HUF Significant interest of Key Management Person Dividend paid 1642000 None 1642000 0 0
30 PREMIER EXPLOSIVES LIMIED T MALTI Relative of Key Management Person Dividend paid 51000 None 51000 0 0
31 PREMIER EXPLOSIVES LIMIED T SRUTHI Relative of Key Management Person Dividend paid 0 None 0 0 0
32 PREMIER EXPLOSIVES LIMIED PELNEXT DEFENCE SYSTEMS PRIVATE LIMITED Wholly owned subsidiary Interest received 29000 None 29000 412000 438000
33 PREMIER EXPLOSIVES LIMIED PELNEXT DEFENCE SYSTEMS PRIVATE LIMITED Wholly owned subsidiary Any other transaction Reimbursement of expenses 2000 None 2000 0 0
34 PREMIER EXPLOSIVES LIMIED PELNEXT DEFENCE SYSTEMS PRIVATE LIMITED Wholly owned subsidiary Investment 100000 None 0 100000 100000
35 PREMIER EXPLOSIVES LIMIED SHONIKA PRASAD Independent Director Any other transaction Sitting fee 113000 None 113000 0 0
36 PREMIER EXPLOSIVES LIMIED KUMUDA RAGHAVAN Independent Director Any other transaction Sitting fee 100000 None 100000 0 0
37 PREMIER EXPLOSIVES LIMIED Dr GNANASEKHARAN VENKATASAMY Independent Director Any other transaction Sitting fee 120000 None 120000 0 0
38 PREMIER EXPLOSIVES LIMIED Dr NAREDRA KUMAR NANDA Independent Director Any other transaction Sitting fee 120000 None 120000 0 0
39 PREMIER EXPLOSIVES LIMIED SESHAGIRI RAO CHITTAVARJULA Independent Director Any other transaction Sitting fee 150000 None 150000 0 0
Total value of transaction during the reporting period 107823000





Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt